imperatorin has been researched along with cardiovascular agents in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KHADZHAI, IaI; KUZENTSOVA, V | 1 |
| Cao, Y; Duan, H; He, L; Zhan, Y; Zhang, Y | 1 |
| Guo, M; Hu, H; Huang, H; Nasser, MI; Zhu, P; Zhu, S | 1 |
1 review(s) available for imperatorin and cardiovascular agents
| Article | Year |
|---|---|
Effects of imperatorin in the cardiovascular system and cancer.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System; Furocoumarins; Humans; Inflammation Mediators; Neoplasms; Oxidative Stress; Signal Transduction | 2019 |
2 other study(ies) available for imperatorin and cardiovascular agents
| Article | Year |
|---|---|
[Some pharmacological data on the action of imperatorin].
Topics: Cardiovascular Agents; Furocoumarins; Khellin; Muscle Relaxants, Central | 1962 |
Furanocoumarins-imperatorin inhibits myocardial hypertrophy both in vitro and in vivo.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Cells, Cultured; Furocoumarins; Heart Failure; Molecular Structure; Myocardium; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley | 2010 |